COMPANY PROFILE / #853
Beacon Biosignals
Developer of an artificial intelligence-based neurotechnology platform designed for accelerating the clinical development of therapeutics targeting brain health. The company's platform utilizes FDA-cleared headband devices to collect high-fidelity sleep electroencephalogram and applies AI algorithms to characterize brain function, detect novel biomarkers, enabling clinical research teams to optimize treatment impact.Privately Held (backing)
已融资122
最新估值—
员工数—
成立年份Precision Neuroscience, Kernel (Monitoring Equipment), Neuralink, EMOTIV, Muse (Monitoring Equipment), Paradromics, PhysIQ, AliveCor, NeuroSky, Phantom Neuro, NeuroPace, Mainstay Medical, ImmersiveTouch, SHL Telemedicine, Neurable, BioBeats, MindMaze Therapeutics Holding, Nanolive, Osso VR
公司概况
- Companies
- Beacon Biosignals
- Description
- —
- Website
- Boston, MA
- HQ Location
- Developer of an artificial intelligence-based neurotechnology platform designed for accelerating the clinical development of therapeutics targeting brain health. The company's platform utilizes FDA-cleared headband devices to collect high-fidelity sleep electroencephalogram and applies AI algorithms to characterize brain function, detect novel biomarkers, enabling clinical research teams to optimize treatment impact.
- Year Founded
- Precision Neuroscience, Kernel (Monitoring Equipment), Neuralink, EMOTIV, Muse (Monitoring Equipment), Paradromics, PhysIQ, AliveCor, NeuroSky, Phantom Neuro, NeuroPace, Mainstay Medical, ImmersiveTouch, SHL Telemedicine, Neurable, BioBeats, MindMaze Therapeutics Holding, Nanolive, Osso VR
- Keywords
- 2026: 122, 2025: 100, 2024: 78 E, 2023: 55, 2022: 34, 2021: 20
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 122
- First Financing Date
- —
- First Financing Size
- 96
- First Financing Valuation
- jarrett@beacon.bio
- Last Financing Date
- 0.71%
- Last Financing Deal Type
- 31-Mar-2026
- Last Financing Size
- Secondary Transaction - Private
- Last Financing Valuation
- —
- Last Financing Status
- —
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- 0.05
- Valuation Estimate
- 01-Oct-2025
- Valuation Estimate Growth Rate
- ai platform, brain computer interface, diagnostic data, eeg data, empathic computing, neural implants, neurological care, neurological device, neuromodulation device, neurostimulation device, neurotechnology, neurotechnology platform, sleep data, treatment assessment
- Active Investors
- Venture Capital-Backed
- # Active Investors
- 5%
- Acquirers
- Alumni Ventures, Andrew Hollenbeck, Casdin Capital, Catalio Capital Management, General Catalyst, GV, Half Court Ventures, Iaso Ventures, Indicator Ventures, Innoviva, JSL Health Capital, Kicker Ventures, Logos Capital, Palo Santo, S32, Samsung NEXT Ventures, Synetro Group, Takeda Digital Ventures
团队与联系人
- Employees
- —
- Employee Growth %
- 2019
- Employee History
- —
- Primary Contact
- 132.00
- Primary Contact Title
- +1 (800) 952-5210
- Primary Contact Email
- Jarrett Revels
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 57.38%
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- 264
- Size Multiple
- —
- Size Multiple % Change
- 334.00
- Size Multiple Change
- 0.00%
- Size Multiple Percentile
- 0.00x
- Majestic Referring Domains
- 12.70x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- 07-Feb-2019
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 2,511
- Success Probability Over Time – 1 Year
- 23%
- Success Probability Over Time – 3 Year
- 34%
- Success Probability Over Time – 5 Year
- Co-Founder & Chief Technology Officer
记录来源：public.companies · 原始序号 #853 · 所有字段均按数据库原值展示。